VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
about
The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrityGene therapy for ischemic heart diseaseGene Therapy for Cardiovascular DiseaseTherapeutic angiogenesis for cardiovascular diseaseRegeneration strategies after the adult mammalian central nervous system injury-biomaterialsApplication and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic CardiomyopathyGene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationExtracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineEngineering the matrix microenvironment for cell delivery and engraftment for tissue repairLong-term delivery of protein therapeuticsTherapeutic angiogenesis: controlled delivery of angiogenic factors.Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting MoleculesMolecular Connections between Cancer Cell Metabolism and the Tumor MicroenvironmentRestoring transcription factor HoxA5 expression inhibits the growth of experimental hemangiomas in the brainTissue engineering and regenerative medicine -where do we stand?Distinct and opposite roles for SH2 and SH3 domains of v-src in embryo survival and hemangiosarcoma formation.Changes in the cochlear vasculature and vascular endothelial growth factor and its receptors in the aging c57 mouse cochlea.Angiomyogenesis for myocardial repair.Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells.Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarctionIncreased revascularization efficacy after administration of an adenovirus encoding VEGF(121).Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model.Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy.VEGF gene therapy augments localized angiogenesis and promotes anastomotic wound healing: a pilot study in a clinically relevant animal model.Regulation of hypoxic response elements on the expression of vascular endothelial growth factor gene transfected to rat skeletal myoblasts under hypoxic environment.Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Adeno associated viral vector-delivered and hypoxia response element-regulated CD151 expression in ischemic rat heart.Role of vascular networks in extending glucose sensor function: Impact of angiogenesis and lymphangiogenesis on continuous glucose monitoring in vivo.Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent.Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels.Research in pharmacotherapy for erectile dysfunctionPolymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation.Serum-dependence of affinity-mediated VEGF release from biomimetic microspheresHuman Muscle Precursor Cells Overexpressing PGC-1α Enhance Early Skeletal Muscle Tissue FormationBone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia.Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart modelConditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.Clinical applications of vascular gene therapy.Implanted cell-dense prevascularized tissues develop functional vasculature that supports reoxygenation after thrombosis.Treatment of mouse limb ischemia with an integrative hypoxia-responsive vector expressing the vascular endothelial growth factor gene.
P2860
Q24304367-DB24DA77-CD5F-4CB5-AF0E-C832BD3A5B31Q24632135-72B5790E-AC28-4891-95D7-01C7065CD56CQ24791063-1DFD53C5-D5C2-4B98-A548-97C5E314C95AQ24799337-32282648-46DD-4D99-84A7-083C2F47D8BCQ26752004-B09318CB-C04F-44BB-8FE5-5B4F516968D6Q26796004-F1B69508-2FD7-4AE6-83C0-8C13DBE6145EQ26799437-CD72B65F-46AB-4CBF-9696-4322B158B96FQ26829783-9C6C1C35-CFDD-47DA-BDAF-86042125824EQ26852370-8C08E271-1CF7-4BDB-8C5A-BFF8E747E494Q26860505-CBC4D788-D0E3-4288-8C05-C59A73DF2214Q27023731-9958A3BE-E968-481E-8598-17384FB390F7Q27303518-5A196432-3CAC-4BAE-880D-CF0E6989FEE9Q28081657-BEFABA28-C7AF-46B2-918E-273E14E763F9Q28245688-82C6FAA1-47DD-4B6B-BCEF-B31EE852C066Q28661692-F0468A91-3256-4EBD-A5EB-1B1477E8C190Q30160161-158211B2-807A-4307-A784-31BEC12BFE21Q30451019-A1E0DCA7-DCA0-4CD3-9AF2-99E28EFEBFD9Q30480151-4F5FCA9A-A6C6-4A2E-87B1-B43B73489D5DQ30539770-F1AF25D7-3C80-4C9A-9521-8D4F35AF2A63Q30580723-467D9589-4C65-4061-A46C-A9263B53831AQ30758542-60D26CFA-36B7-4DD5-97AC-03D3C01DD57CQ33224509-BAC9485D-DB23-4B3C-8F77-56C7DE16CC61Q33258465-FEE306A7-3549-4971-B5B6-98D5468352EBQ33360810-5F680B74-1CFE-4482-8BA2-78897DE6E343Q33375103-BD024341-25E1-442B-B9E1-B61ABA8AEB9CQ33556657-39E33DAA-BF97-46C1-BE4D-26A485FA8EC7Q33565700-9EEA0F6D-6936-4546-82D1-4DB02F26D712Q33574053-E31937ED-DAD4-4482-A154-99C139C66B7FQ33586324-2AA36762-C14A-4E1E-9870-B3AF996BA5CBQ33586957-7B42F6E4-1C0A-48C3-AD7F-C2B64D72DFF3Q33650796-2E20535D-847F-46A1-B88A-EE60700A3835Q33653191-7EBE9311-631B-4807-91B3-056BD13D6759Q33761778-7B2ED993-FC90-4D3F-8743-AFC3A2C74046Q33792967-838620FF-A735-405B-807B-8532FE4A23C9Q34011783-C1902884-8407-49B3-9E66-3AF4F5D58C4BQ34035800-AB51B084-79F0-445F-A2AF-2FD572E02608Q34086442-5266779D-90A4-43F1-84F1-B93EB2B53CBAQ34119449-6689E235-08AE-4E22-8995-25B00DACE4BFQ34164871-B8174098-400E-421F-BF7F-A8CDF05AFD03Q34217612-F475A68A-3D74-44B5-A4BC-19D58CCA15EA
P2860
VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
@en
type
label
VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
@en
prefLabel
VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
@en
P2093
P356
P1433
P1476
VEGF gene delivery to myocardium: deleterious effects of unregulated expression.
@en
P2093
P304
P356
10.1161/01.CIR.102.8.898
P407
P577
2000-08-01T00:00:00Z